Triplixam 5 mg/1,25 mg/5 mg 15 tablets

Triplixam 5 mg/1,25 mg/5 mg 15 tablets

Composition:

Per tablet:
Perindopril arginine — 5 mg;
Indapamide — 1.25 mg;
Amlodipine — 5 mg.

Description of the product:

Triplixam is a fixed‑dose combination medication used in the treatment of arterial hypertension and cardiovascular conditions.
It combines an ACE inhibitor (perindopril), a thiazide‑like diuretic (indapamide), and a calcium channel blocker (amlodipine), providing comprehensive blood pressure control and cardiovascular protection.

Indications for use:

Treatment of arterial hypertension.
Reduction of cardiovascular risk in patients with high blood pressure.
Support of heart and vascular function in patients requiring combination therapy.

Method of administration and dosage:

Adults: One tablet daily, preferably in the morning before meals.
Follow physician’s instructions and package labeling.

Contraindications:

• Hypersensitivity to any of the active substances or excipients.
• Severe hepatic or renal impairment.
• Cardiogenic shock, severe hypotension.
• Pregnancy and breastfeeding.

Precautions:

Use with caution in patients with electrolyte imbalance, diabetes mellitus, or chronic kidney disease.
Regular monitoring of blood pressure and laboratory parameters is recommended.

Side effects:

Common: headache, dizziness, cough, edema, fatigue.
Rare: allergic reactions, electrolyte disturbances, liver function changes.

Pregnancy and lactation:

Contraindicated.
Alternative antihypertensive therapy should be considered.

Storage conditions:

Store in a dry place at temperatures below 25°C.
Keep out of reach of children.

Packaging:

Carton box containing blister packs of 15 film‑coated tablets.